Delivery Order SPE2DB20D2104-SPE2DB25FMPJV

Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,903.46, is for the delivery of FYCOMPA 0.5 MG/ML oral suspension in 340 ML containers. This is a Firm Fixed Price Delivery Order contract with a period of performance through March 20, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. The contract is a Delivery Order with a Firm Fixed Price of $2,903.46 and an Ultimate Completion Date of January 29, 2025. The contract is not designated as a Set-Aside. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FYCOMPA 0.5 mg/ml oral suspension in 340 ml quantities, with a ceiling value of $3,194.49. It is a firm fixed-price contract with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of FYCOMPA 0.5 MG/ML oral suspension (340 mL) with a potential value of $1,924.48 and a completion date of February 28, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds an Indefinite Delivery...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,455.20 firm fixed price contract is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a medication. The contract has a completion date of February 7, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,244.15, is for the supply of FYCOMPA 10 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product FYCOMPA 8 MG TABLET 30S. The contract has a ceiling value of $2,101.56 and a period of performance through August 8, 2024. The contract is a firm-fixed-price arrangement and does not utilize a socioeconomic set-aside. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which is issued under a larger...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Fycompa 0.5 mg/ml oral suspension in 340 ml containers. The contract has a ceiling value of $7,287.00 and a period of performance through February 4, 2025. It is a firm-fixed-price contract type. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds several large...
This federal contract award, valued at $4,342.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a pharmaceutical product. The contract is a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This is a $1,509.13 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FYCOMPA 12 MG TABLET 30S. The contract has a ceiling value of $1,509.13 and a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMPJV
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a pharmaceutical product, with a ceiling value of $5,806.92 and a performance period ending on April 28, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 7/25/25, 11:22 AM